Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese

被引：0
作者：
Chin-Hsiao Tseng
机构：
[1] National Taiwan University College of Medicine,Department of Internal Medicine
[2] National Taiwan University Hospital,Division of Endocrinology and Metabolism, Department of Internal Medicine
[3] Division of Environmental Health and Occupational Medicine of the National Health Research Institutes,undefined
来源：
BMC Cancer | / 15卷
关键词：
Diabetes mellitus; Non-melanoma skin cancer; Rosiglitazone; Taiwan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 82 条
  • [1] Kuenzli S(2003)Peroxisome proliferator-activated receptors in cutaneous biology Br J Dermatol 149 229-36
  • [2] Saurat JH(2007)Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease Biochim Biophys Acta 1771 991-8
  • [3] Michalik L(2006)Peroxisome proliferator-activated receptors increase human sebum production J Invest Dermatol 126 2002-9
  • [4] Wahli W(2005)BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application J Pharmacol Exp Ther 315 996-1004
  • [5] Trivedi NR(2005)Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis Expert Opin Pharmacother 6 1455-61
  • [6] Cong Z(2006)Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease Expert Opin Investig Drugs 15 1453-68
  • [7] Nelson AM(2004)PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis Carcinogenesis 25 1747-55
  • [8] Albert AJ(2005)The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin Mol Carcinog 43 198-206
  • [9] Rosamilia LL(2006)Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity Cancer Res 66 1873-8
  • [10] Sivarajah S(2012)Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data Diabetologia 55 654-65
123456789